Posted by Michael Wonder on 02 Jan 2020
More drug makers hike U.S. prices as new year begins
2 January 2020 - Drug makers including Bristol-Myers Squibb, Gilead Sciences, and Biogen hiked U.S. list prices on more than 50 drugs on Wednesday, bringing total New Year’s Day drug price increases to more than 250, according to data analyzed by healthcare research firm 3 Axis Advisors.
Reuters reported on Tuesday that drugmakers including Pfizer, GlaxoSmithKline and Sanofi were planning to increase prices on more than 200 drugs in the United States on 1 January.
Nearly all of the price increases are below 10% and the median price increase is around 5%, according to 3 Axis.
More early year price increases could still be announced.
